SCHEMBL8988016

SCHEMBL8988016

CC(=O)Oc1cc2c(c(O)c1O)[C@H]1CC[C@]3(C)C(=O)CC[C@H]3[C@@H]1[C@H](C)C2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 16/20 0.40
HSD17B1 P14061 6/20 0.40
ESR1 P03372 2/20 0.40
CYP3A4 P08684 2/20 0.39
STS P08842 2/20 0.39
AKR1B10 O60218 1/20 0.39
LMNA P02545 1/20 0.39
SHBG P04278 1/20 0.39
CYP1A2 P05177 1/20 0.39
PGR P06401 1/20 0.39
SERPINA6 P08185 1/20 0.39
AR P10275 1/20 0.39
MAPT P10636 1/20 0.39
AKR1B1 P15121 1/20 0.39
NFKB1 P19838 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRM1 P35372 1/20 0.39
SNCA P37840 1/20 0.39
HTR2B P41595 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8988145 0.83 SHBG (0.36) STSSHBGMAPT
SCHEMBL8969620 0.82 CYP19A1 (0.54) CYP19A1HSD17B1ESR1CYP3A4STS
SCHEMBL5496012 0.78 CYP19A1 (0.49) CYP19A1HSD17B1ESR1CYP3A4STS
SCHEMBL8775986 0.77 CYP3A4 (0.54) CYP19A1HSD17B1ESR1CYP3A4STS
Almestrone SCHEMBL1657631 0.72 CYP19A1 (0.65) CYP19A1HSD17B1ESR1CYP3A4STS
Almestrone SCHEMBL8089798 0.72 CYP19A1 (0.65) CYP19A1HSD17B1ESR1CYP3A4STS
Almestrone SCHEMBL12364585 0.72 CYP19A1 (0.65) CYP19A1HSD17B1ESR1CYP3A4STS
Almestrone SCHEMBL13216952 0.72 CYP19A1 (0.65) CYP19A1HSD17B1ESR1CYP3A4STS
Almestrone SCHEMBL12364346 0.72 CYP19A1 (0.65) CYP19A1HSD17B1ESR1CYP3A4STS
Almestrone SCHEMBL5983577 0.72 CYP19A1 (0.65) CYP19A1HSD17B1ESR1CYP3A4STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0719276-A1 ORALLY ACTIVE DERIVATIVES OF 1,3,5(10)-ESTRATRIENE THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-07-03 EP disclosed